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Biological Effects of Low Doses of Ionizing Radiations:
Particle Tracks in Radiobiology
Robert Katz
University of Nebraska–Lincoln, Lincoln NE 68588-0111, U.S.A.

Werner Hofmann
Division of Biophysics, University of Salzburg, Erzabt-Klotz-Str. 11, A-5020 Salzburg, Austria
Abstract
A radiation field is made up of a tangle of particle tracks, from the primary particle and secondary and higher generation electron
interactions, well isolated at low doses and with multiple intersections in cell nuclei at high doses. Low dose effects in multicellular systems are therefore the sum of individual track structures. Until we can state with confidence the structure of a particle track
in biological matter for all end-points of interest, at least as well as we can for nuclear emulsions, our knowledge of low dose effects should be regarded as uncertain and inadequate. In this context “track structure” means the response of physical and biological systems along the path of the particle, and depends on the observed end-point as well as on the identity of the particle. For
mammalian cell killing and a few other biological end-points, track theory and experimental radiosensitivity parameters allow
us to construct schematic models. If we take a particle track to consist of a sequence of inactivated cells strung along the path of a
particle, neither electrons nor protons leave a track in a compact mammalian cell structure. At most there is an occasional killed
cell at the end of the range of a proton or an electron where the particle stops in the nucleus of a cell, with probability less than 0.3
for a proton, and less than 0.01 for an electron. The variety of potential targets whose size may be compared to the measured inactivation cross-section and the lack of a fully consistent theory of RBE make it impossible to decide, from this information alone,
whether cell killing is an individual (1-hit) or cooperative (many-hit) phenomenon, especially for electrons. A similar analysis of
epidemiological data for cancer induction leads to probabilities and action cross-sections so low as to make a linear extrapolation
implausible. In assigning quality factors at highest LET values we should consider that heavy ions inactivate cells, so that neither
mutation nor transformation can represent a hazard. At low doses, when only isolated inactivated cells are produced whose function may be restored by repopulation, it is difficult to see why high LET radiations are assigned the highest quality factors.

light also affects our perception of the “end-point.” The
words “track,” “detector,” and “end-point” are intended
to encompass all of these questions.
In most cases of radiation exposure of the general
public, or of occupational exposure of the individual,
man is exposed to low levels of ionizing radiations. Despite the importance of low dose effects, no exact definition exists of what is meant by “low.” Typically low
doses can be expected in environmental natural background exposure. In the context of this paper we speak
of low doses when biological targets, such as cells or cell
organelles, are traversed only by single charged particles and their associated δ-rays, and where intertrack interactions can be neglected. Although man is exposed
to low dose levels during his entire lifetime, only rough
and controversial information can be derived from epidemiological investigations, the main problem being the
synergistic interference of other environmental factors,
e.g. co-carcinogens. Their interference can be minimized

1. Introduction
The term “particle track” is commonly used in physics and in radiation biology in a variety of ways. Unless
otherwise stated we will here use the words “particle
track” to relate to the pattern of effect generated in the
physical or biological detector by the passage of the primary particle and its associated secondary and higher
generation δ-rays, such as the pattern of developed
grains in nuclear emulsions or of inactivated cells in biological matter. We must be aware that the structure of
the track depends on the end-point being observed. In a
photographic emulsion the pattern of developed grains
can be altered, both qualitatively and quantitatively by
changes in developer composition, dilution, temperature, and time. We must expect that the track structure
in emulsion would also be different if the observation
was made with an ultra-violet microscope, for the size
of a developed grain in relation to the wavelength of
433
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at higher radiation doses. Thus we may take uranium
miner data as representative of the human reaction to
radon decay products, or we may seek to improve the
statistical accuracy of in-vitro cellular experiments, or of
in-vivo animal experiments by high dose exposures. In
general radiobiological experiments at high doses are
reasonably well understood. The problem of radiation
effects at low doses is therefore mainly the problem of
extrapolation from high to low doses and must be based
on theoretical assumptions. Depending on the theoretical model used, different results are obtained at low
doses [1]. It is therefore of utmost importance that the
model used for extrapolation be testable at low doses
with other detectors than biological systems, but whose
response to radiation can be thought to parallel biological response in some significant way.
Experiment alone cannot provide an evaluation between dose and effect at levels of risk between 10–5 and
10–7 Gy–1 needed for estimating radiation hazards to
large populations [2].
In first approximation such effects arise from the interaction of isolated energetic particles with biological
targets. The low dose problem thus reduces to one of
understanding the structure of a particle track in biological matter for the required variety of end-points. Until this can be accomplished our knowledge of the biological effects of low doses of ionizing radiations must
be regarded as incomplete and speculative. Our knowledge of the structure of particle tracks, of low dose effects, must come from an interpretation of high dose effects. For this reason cell killing is the main biological
end-point considered in the present context.
We have achieved a detailed model of cell killing by
high LET radiations of demonstrated predictive value,
and from which it is possible to extract a description of
the structure of individual particle tracks (for this endpoint) from cell survival experiments at high doses with
high LET radiations, such as beams of energetic heavy
particles. However, mutagenesis and transformation toward malignancy are also discussed here, for these represent the most important genetic and somatic hazards
to man, though the experimental data are much more
limited.
Selective stains which reveal the tracks of charged
particles for end-points of interest are either only partially available or fail to ascertain that the effects are
produced by single particles. To develop a picture of
particle tracks in biology we must rely on a theory of biological response to radiations of different quality which
is so constructed as to parallel a theory of particle tracks
in nuclear emulsions, and which has been tested there
and in a variety of other detectors. If the theory reasonably describes bulk effects in emulsions and other detectors, and particle tracks in emulsions, while also describing bulk effects in biology, we may have some
confidence in its extrapolation to particle tracks in biol-
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ogy, and hence to the effects of low levels of radiation.
Neither the theories which describe biological effects
nor those which describe particle tracks in emulsion can
be considered exact. Nevertheless they form a logical
and computational structure which describes patterns of
response of both biological and physical detectors to arbitrary radiation fields.
2. The 1-or-more hit detector
One-or-more hit detectors are characterized as having an exponential response to dose and a decline in
response with an increase in the “LET” of the incident
radiation.
The LET or “linear energy transfer” refers to a variety
of restricted energy loss, or stopping power [3]. In the
present context we imply no restriction and use the term
LET to imply LET∞, the total rate of energy loss.
To describe the properties of a 1- (or-more) hit detector theory requires knowledge of the following detector
parameters: E0, the dose of gamma-rays at which there is
an average of 1-hit per target, 0, the radius of the target
2
(or κ = E00 /2 × 10–2 J–1 m), and N0, the number density
of targets, as well as the fact that the detector responds
exponentially to radiations, in the form of the 1-or-more
hit cumulative Poisson distribution. Together with the
parameters of the ionizing particle, the radial distribution of the average local dose about the path of an ion,
Ē(z*, β, t, 0), is needed. Here z* is the effective charge
number of the ion, β is its speed relative to the speed of
light, and t is the radial distance from the ion’s path to
the center of the sensitive target. This distribution can be
determined, either from measurement or by calculation
from the properties of the medium, knowledge of δ-ray
production, and of the subsequent electron interactions
by which the energy lost by the heavy ion is transferred
to the medium.
Neither the parameters of the detector nor the radial
distribution of dose are known precisely. Nevertheless
the relationships are such that with some adjustment of
parameters the overall form of the detector response to
radiations of different “LET” and the structure of a particle track can be well fitted and even predicted by the
theory.
Typically the point distribution in local dose is given
by an expression of the form
E(t) = C1z*2/β 2 t 2

(1)

from a radial distance t  15 nm to a maximal range tmax
which lies in the neighborhood of
tmax = C2T 5/3,

(2)

for a particle with kinetic energy per unit mass of value
T.
The only available experimental data [4,5] yield val-
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ues of C1, in water, in the neighborhood of 150 Gy nm2,
within 25% fluctuation, while calculations [5,6,8] yield
similar values. The constant C2 has the value 0.25 μm
(MeV/amu)–5/3, for tmax is in μm when T is in MeV/amu.
The average local dose Ē can then be obtained by averaging the point dose E over the sensitive site of radius 0
centered at a radial distance t from the ion’s path.
The theory of the 1-hit detector describes the behavior of normally developed sensitive nuclear emulsions
very well [9]. In essence we find the radial distribution
in effect about an ion’s path from the radial distribution
in local dose deposited by delta electrons [equation (l)]
and the response of the detector to gamma-rays. For a
uniform irradiation by gamma-rays with dose D, the
dose-response relationship for a 1-hit detector is described by
P(D) = 1 – e–D/E0 .

(3)

Substituting Ē for D, then enables us to calculate the
linear density of developed grains, the track width or
opacity, and to prepare computer models of particle
tracks whose appearance compares well with microphotographs of real tracks [10-13]. The radiosensitivity parameters of the emulsion are partly obtainable from the
manufacturer (0 and N0), while E0 is sometimes measured from sensitometry after gamma-irradiation, and is
sometimes fitted to the appearance of a particle track.
The theory of the 1-hit detector also provides a very
good description of the variation of the inactivation
cross-sections of dry enzymes and viruses bombarded
by heavy ion beams of different “LET.” Here the cross
section σ is identified with the radially integrated probability P of inactivation of the targets, the enzyme or virus molecules, by the passage of a single ion:
⌠ tmax
σ= ⌡
2πtP dt.
0

(4)

The decline in the yield of single strand break events
in Φx-174 with an increase in “LET” [14] suggests that
this is also a 1-hit process. Indeed single strand break
events are defined by the authors as l-or-more breaks
in a strand of the DNA double helix, as consistent with
a l-or-more hit process. We have been able to fit these
strand break data with the assumption that this process
is described by the parameters E0 = 7 kGy and 0 = 10
nm, not far from the parameters used in describing the
inactivation of this virus [8]. To reasonable approximation radical production is also a 1-hit process, often of
biological interest.
Particle tracks in these biological 1-hit detectors, with
inactivation as the biological end-point, will have similar appearance to particle tracks in 1-hit emulsions, except for questions of scale. Indeed, exactly the same procedure used for emulsions [12] may be followed to yield
the tracks in these biological detectors. The tracks will
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exhibit a grain-count regime, where the inactivated targets are openly strung along the ion’s path like beads
on a string, when the probability P for inactivating targets traversed by the ion is small. In this case the inactivation cross-section is also small when compared to
the geometric cross-section. With increasing “LET,” as
for a heavier or a slower ion, the inactivated targets are
strung more closely together to present an increasingly
filled “core” and a developing “track-width,” as the inactivation cross-section exceeds the geometrical crosssection of the target. Experiments with virus inactivation have found inactivation cross-sections more than
an order of magnitude greater than the geometric crosssection, while with emulsions the track width has been
observed to be as much as 100 times the diameter of the
undeveloped emulsion grain.
In general, the tracks formed by charged particles in
1-hit detectors are reasonably well understood. For such
detectors we can claim to understand the effects of low
doses of ionizing radiations. For 1-hit detectors the linear extrapolation to low dose is precisely correct.
3. Biological cells
Our understanding of the structure of particle tracks
in tissue, or in a matrix of biological cells in-vitro, poses
a much more severe problem, different for every different end-point. We do not truly know the size nor the location of the sensitive targets, nor the number of these
targets which must be hit to yield a particular end-point,
aside from saying that they are in the nucleus or that
they may be associated with the DNA or with the nuclear membrane [15]. Repair processes affect biological
response, but we have no quantitative understanding
of the effects of radiation on these processes. We cannot be certain as to the shape of survival curves or of
other dose-effect relationships, especially at low doses.
Most analyses take the form of statistical curve fitting to
high dose data, but these suffer from the inherent problem that the statistical models assume a homogeneous
population, while experimental populations are heterogeneous [15]. It is currently popular (widely accepted)
to use a linear-quadratic model, but such a model is by
no means uniquely fitted to the available data.
It has been argued that there is an intimate relationship between the shape of the survival curve after
gamma-irradiation (low “LET”) and the “RBE” after
high “LET” irradiations [17]. According to the ICRU [3],
the Relative Biological Effectiveness (RBE) is defined as
the ratio of the absorbed dose of a reference radiation
to the absorbed dose of a test radiation to produce the
same level of biological effect, other things being equal.
The relationship between low and high LET radiations
is based on the assumption inherent to track theory that
the difference between low and high “LET” radiations
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lies in (1) the temporal scale of the irradiation and (2)
the microscopic concentration of local dose about the
path of a heavy ion, and that sensitive targets respond to
the dose of secondary electrons, irrespective of their origin. To the extent that temporal differences may be neglected, it follows that the probability for cell killing relative to the absorbed dose after gamma irradiation must
be supralinear if an RBE greater than 1 is to be observed
for any high “LET” radiation. For a more extensive discussion of these problems the reader is referred to references 15, 17-20.
When considering this problem from a theoretical
viewpoint, it is imperative that we ask what the implications of a low “LET” survival curve are for the structure of particle tracks. These, after all, contain a high
dose region close to the particle’s path where dose rate
effects can be of consequence, and a low dose region far
from the path where the question of dose rate is meaningless, because it is unlikely that two electrons from
the same ion pass through the same target or even the
same cell nucleus. In the periphery of an ion’s path the
only difference between delta-rays from a heavy ion
and isolated Compton electrons from a photon irradiation lies in their energy spectra. The question of extrapolation of low doses of low LET radiations cannot
be separated from the question of the RBE of high LET
radiations.
Physical detectors more complex than 1-hit detectors have been treated as C-or-more hit systems, with
four parameters, the hittedness C, E0, 0 (or κ) and N0.
Application of the theory to biological cells whose survival curve after gamma-irradiation is represented by
the multi-target single-hit statistical model, requires
an additional parameter, the cross sectional area of the
nucleus of the cell, for the sensitive sites are distributed throughout the nucleus, perhaps like “beans” in a
“bean-bag.” These parameters are then m, the extrapolation number of the gamma-ray survival curve, or the
number of (1-hit) sensitive subcellular sites which must
be inactivated to inactivate the cell, E0, the dose at which
there is an average of 1-hit per target, κ, the value of
z*2/4β 2 at which the plateau value of the cellular inactivation cross-section is achieved, σ0, the plateau value
of the extrapolated cross-section (which approximates
the geometrical cross-section of the cell nucleus), and
N0, the number density of cells, needed for track simulation, but not for survival curves. Thus for biological cells
there are four fitted parameters from which the formulas of the theory must yield survival curves for an arbitrary radiation field for which we know the particle-energy spectrum [7,21]. The parameters are typically fitted
to survival data for particles used in bombardments at
energies less than 10 MeV/amu, and are then used for
calculations for all radiation fields.
The theory has been tested for neutron and pion irradiations [22], and irradiations with admixtures of neu-

in

Nuclear Instruments

and

M e t h o d s 203 (1982)

trons and gamma-rays [23]. Most recently, in connection with a relatively primitive model of the secondary
fragment production in heavy ion beams, it has been
used to predict the inactivation of T-1 cells as a function of depth in energetic C, He, and Ar beams [24]. Indeed calculations from in-vitro parameters have been
shown to yield in-vivo values of the “RBE” vs. neutron
dose for several different biological end-points [25],
suggesting that the parameters of the model and the
calculations made from it are valid for extrapolation
to the structure of particle tracks in both in-vitro and
in-vivo systems. In sum then, track structure theory in
its extension to the “RBE” of high “LET” radiations has
predictive value in spite of a not completely resolved
conflict [17,19] between experiment and the demands
of the theory in regard to the initial slope of the survival curve after gamma-irradiation. The success of
the theory with heavy ion irradiations [24], and with
mixed radiation environments [22,23] does account for
the effects of particle track structure in high “LET” irradiations and therefore lends itself to a calculation of
the structure of the tracks of single particles in biological matter.
4. Particle tracks in biological matter
According to track theory, an ion of atomic number
Z, effective charge number z*, given by
–2/3

z* = Z[1 – e–125βZ

],

(5)

when moving at speed β relative to the speed of light,
has probability P for inactivating a cell whose nucleus it
threads, given by
2

P = [1 – e–z*2/κβ ]m.

(6)

For T-1 cells, aerobically irradiated, κ = 1000 and m =
2.5. Equation (6) describes the inactivation probability in the “grain-count” regime, where inactivated cells
lie along the ion’s path, like beads on a string. Interested only in relatively low Z particles, we can here neglect the “track-width” regime. With the aid of equation (6), knowledge of the radiosensitivity parameters
κ, m [7,21] and N0, and a table of residual range R vs. β
in water, we are able to construct a picture of the track
of a heavy ion in biological matter with inactivation as
the end-point.
To simulate a track we divide the path of the ion into
range intervals li, at β = 0, 0.01, 0.02, . . . and find Pi from
βi at the high energy end-point of each interval. If the
average distance between the centers of the cells is λ,
then the average number of cells in the ith interval is li/
λ, and the average number of cells killed in the ith interval is P i l i /λ. These cells are placed at random in the ith
interval.
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Particle Tracks in “Close Packed” T-1 Human Kidney Cells (Aerobic)
in 1 mm segments

‡ indicates position of Bragg peak.
Each cell is taken to have a diameter of 10 microns, with the leftmost end of the first cell at the residual
range indicated at left. Cells are close-packed and aligned along the ion’s path.
 indicates a cell killed by a heavy ion moving from right to left, in the “ion-kill mode.”
 indicates a cell whose nucleus has been intersected by the moving heavy ion and which experiences
only sub-lethal damage.
Figure 1. Schematic simulation of the tracks of heavy ions in an “emulsion” of aligned, close-packed cells (at 10 μm intervals) having the radiosensitivity parameters of aerobically irradiated T-1 kidney cells.

Figure 1 shows particle tracks constructed for cells
having the radiosensitivity parameters of aerobically
irradiated T-1 kidney cells. These are assumed to form
a close packed structure with N0 = 106 cells/mm3 and

with cell spacing λ = 10 μm. Track segments 1 mm long
are shown, at selected ranges, slowing down from right
to left, for ions from protons to argon.
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Figure 2. Γ (= ∫PdR) in cm, vs. range T, in cm, for different ions
in a cellular matrix. The average number of cells killed by an
ion of residual range R is found by dividing Γ by the average
distance between intersections, λ. The fraction of intersected
cells killed by an ion is Γ/R.

A second representation of these data is given in Figure 2, displayed in a different manner. Using the same
formulation we calculate Γ = ∑Pili and R = ∑li . Since Γ/
R is the fraction of intersected cells inactivated by a particle of range R, the 45° line represents residual range
values at which each traversed cell will be killed. Multiplying Γ/R by the total number of cells along the particle range, R/λ, the number of cells inactivated by a particle of residual range R will be Γ/λ.
We must issue a cautionary note about the quality of
the simulation at the very end of the track, where the
range of delta-rays may be too small to bathe even several of the sensitive elements of a cell, let alone an entire
cell nucleus, as may be seen from equation (2). A similar
cautionary note deals with cells whose nuclei are barely
grazed by the ion’s path, but which may be inactivated
by its delta-rays, as we see from equation (1). Taking C1
there to be 130 Gy nm2, we calculate that an 86Rn ion at
β = 0.15, with T = 10.66 MeV/amu, has z*2/β 2 = 1.255 ×
105. This leads to tmax = 12.6 μm, and to a local dose of
1.8 Gy at t = 3 μm. The existence of a predicted cellular
track-width regime has recently been verified with bacterial spores [27] and yeast cells [28].
Experiments by Goodhead et al. [29] yield the estimate that helium ions at 90 keV/μm produce 0.03 to 0.06
lethal lesions/μm through nuclei 7 μm thick in mammalian cells. This finding is in reasonable agreement with
our calculation for T-1 kidney cells, where we find P =
0.36 at β = 0.06, where the stopping power is 77 keV/μm.
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Experiments by Datta et al. [30] with 24lAm alpha particles find that the greatest inactivation probability for helium ions which stop in the nucleus of a cell is 0.43, and
that this probability drops both for lower and for higher
energies. For comparison our estimate for a helium ion
having a range of 8 μm is 0.8. Experiments by Lloyd et
al. [31] give similar results. There are some interpretive
problems associated with the determination of the crosssectional area of a plated nucleus, estimated by different investigators as from 40 to 300 μm2, leading to discrepancies in the estimated probability for killing by an
alpha particle. Thus there are problems which remain
unsolved in both calculation and measurement. Within
this grey area, however, calculation and experimental
results agree, even for stopping helium ions. Contrary
to the situation with alpha particles, there are unfortunately no comparable experimental data for protons. In
Figure 1 we have represented the last cell whose nucleus
is intersected by a proton as killed. This is an overestimate, for our calculations indicate that the probability of
killing the last intersected cell is about 1/3. Once again,
at the very end of the track these calculations probably
overestimate cell killing because of the limited range of
the delta rays. For example, tmax = 0.23 μm at the residual proton range of 6.7 μm. But the diameter of the cell
nucleus may be 8 μm.
The tracks of heavier ions, with cell killing as the endpoint present no particular problems, for all intersected
cells are killed at the very end of the track, where the
greatest uncertainties exist in the calculation. We will return to this point in our discussion of cancer induction.
Since cancer cannot be induced in killed cells, a question
must be raised about the high values assigned to the
quality factor at the highest “LET.”
5. Electron tracks
The evaluation of track structure for electrons in biological systems poses a difficult problem. The fundamental question is: Can a single electron kill a cell? It
is not enough to say that at track-end electrons are high
“LET” particles. As Lloyd et al. [31] have pointed out,
we must consider the probability per unit path length.
And “high LET electrons” have a very limited residual
range.
Track theory starts from the response of a bulk medium to a dose of low “LET” radiation (gamma-rays), a
tangle of electron tracks, and maps this response about
the path of a heavy ion. It therefore does not speak directly to the question of the formation of electron tracks.
To do so requires a theory of electron action cross-sections and a connection between these cross-sections and
a macroscopic dose-effect relationship for a bulk medium. This is a task for future research.

Biological Effects

of

Low Doses

of

Ionizing Radiations

In the framework of the present theory we can estimate the effect of an electron on a biological system by
calculating the probability for cell killing for a “pseudoelectron,” a particle having the charge and mass of an
electron which behaves in accordance with expressions
derived for and tested with heavy ions. Applying equation (6) to this problem, and neglecting branching secondary electrons of sufficient energy to form tracks of
their own, we conclude that Γ = 2.3 × 10–2 μm for a 1
MeV pseudo-electron (range in water about 4 mm) and
2.2 × 10–2 μm for a 15 keV pseudo-electron. It is only at
track end that such a particle has even a slight chance of
killing a cell. However, when an electron moves slowly
enough that the probability of inactivating a cell is large,
its residual range is very small. Taking the mean spacing
between cells to be 10 μm, this particle can be expected
to kill 2.2 × 10–3 cells in a close-packed medium, at 15
keV and 2.3 × 10–3 cells at 1 MeV initial energy, neglecting the production of energetic secondary electrons.
These results are consistent with experimental findings in microbeam irradiations with electrons of 15 keV
initial energy, by Datta et al. [30] who found that about
1,000 electrons incident on the cell over the area of the
nucleus were required to kill a cell. Because of scattering, only about half of these electrons were estimated to
have penetrated the nuclear membrane. This leads to an
estimate that the maximum probability for cell killing by
track-end electrons is 2 × 10–3, for 15 keV electrons were
more effective than incident electrons of either higher or
lower energies in these experiments. As always in any
high fluence experiment, we cannot be certain that the
effect is produced from a single incident electron (ionkill) rather than the cumulative effect of several incident
electrons (gamma-kill). Nor should we infer that a single electron action is involved from the apparent coincidence between action cross-sections and the physical
size of a possible target, as has been suggested by Cole
et al. [32], since action cross-sections may be an order of
magnitude greater or smaller than the actual cross-sectional area of the target [7,8]. Nevertheless the upper
limit established by experiment for the probability that a
15 keV electron inactivates cells agrees with the calculation for “pseudo-electrons.”
Another way of approaching the problem is through
the measured initial slope of survival curves after electron or gamma-ray irradiation. If an electron of initial
energy w and all its secondaries kills v cells when fully
absorbed in a matrix containing N0 cells per unit volume
in a medium of unit density, the initial slope  of the
dose-effect survival curve is given as
 = v/N0w.

(7)

This result is obtained by noting that an irradiation with a
fluence of F electrons per unit mass, of initial energy w deposits a dose D = Fw, while if each electron and all its sec-
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ondaries kills v cells, the fraction of cells killed is Fv/N0.
Inserting these quantities into the usual expression for
the initial slope of the survival curve N/N0 = 1 – D + . . .
leads to equation (7).
Typical in-vitro experiments with mammalian cells
contain a maximum concentration of 105 cells/ml [33].
Then, if 1 MeV electrons produce a survival curve with
initial slope  = 10–5 Gy–1 derived from gamma-irradiation of V-79 cells [34], we find v = 1.6 × 10–6 cells killed
per incident electron and all its secondaries. In these experiments much energy is deposited in the culture medium. To evaluate the effect of a single electron in a cell
culture from which the medium has been extracted, or
for in-vivo tissue experiments, we suppose that N0 = 109
cells/ml, leading to a value of v that is 104 times greater
than before. Then a 1 MeV electron and all its secondaries might kill 1.6 × 10–2 cells when  = 10–5 Gy–1.
We must conclude that an electron does not make
an observable track in tissue, even for a survival curve
whose initial slope is 10 times greater than that for
which the calculation is made. At most an occasional
single cell is inactivated at path end in such a way that
it would be impossible to identify observationally with
single electrons.
6. Other biological end-points
Contrary to cell killing we do not have radiosensitivity parameters for other end-points, such as DNA double
strand breaks, G-2 block, chromosome breaks, transformation, or mutation. At best we can estimate response
relative to cell killing from data like that presented by
Cole et al. [32], which indicates that transformation and
mutation are about 1/400 and 1/40000, respectively, as
likely as lethality from a single alpha particle. On the
other hand double strand breaks are about 10 times
more likely than lethality, while G-2 block and chromosome breaks only about 3 times. For 1 MeV electrons
and all their progeny we can estimate that 1 electron in
24,000 would yield a transformed cell, while one electron in 2,400,000 would yield a mutation.
For such rare events the problem arises that “track”
loses its proper meaning as an observable entity. A particle track can also be regarded as the probability distribution for a defined end-point along an ion’s path,
which becomes observable only if the probability exceeds a certain level. For very low probabilities a specified biological effect in a single cell is likely to arise by
the cooperative action of two or more electrons passing
through the nucleus of the cell when this leads to a joint
probability of appropriate value.
From all the different biological end-points, cancer
induction represents the most important somatic hazard in radiation protection. We thus wish to explore the
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question: What is the probability for a 1 MeV electron
to cause a cancer? Since transformation toward malignancy is regarded as the initial event in carcinogenesis,
in-vitro transformation experiments can supply part of
the needed information. Thus we will get an upper limit
for the probability for cancer induction, because not every transformed cell will develop a tumor. From these
data we can derive a probability for transforming a cell
by a single 1 MeV electron of between 10–4 and 10–5 at
the very end of the path [32,35].
On the other hand a considerable amount of experimental data on cancer frequencies at low doses have
been compiled in epidemiological studies during recent
years [1]. This epidemiological approach considers also
all the synergistic biological mechanisms involved in invivo irradiation as compared to in-vitro transformation
experiments with cell cultures. If we take the cancer risk
to be 10 cancers per rad per 106 persons, as an average
value for different organs and types of radiations [1,36],
a radiation sensitive organ of 104 mm3 having 106 cells/
mm3 of equal susceptibility, then the probability of cancer induction per cell and per rad is 10–15. If a dose of 1
rad (0.06 MeV/cell) were delivered by 1 MeV electrons
(having a path length in tissue of about 4.3 mm and thus
traversing about 430 cells), then about 430 electrons of 1
MeV initial energy must pass through a cell to deposit 1
MeV of energy, or at 1 rad about 25 electrons intersect
the cell. Combining these numbers the probability (on
average) that a single 1 MeV electron intersecting a cell
can lead to an observable tumor is about 4 × 10–17.
Converting the data of Mole [37] for leukemia incidence in Japanese atom bomb survivors (typically exposed to doses exceeding 20 rad), a comparable probability that a 1 MeV electron passing through a bone
marrow cell will lead to leukemia is about 10–18.
Under the assumption [7] that the transformation
cross-section equals the product of the cross-sectional
area of the cell nucleus (10–10 m2) by the probability of
transformation, we find that the above derived probabilities yield a mean transformation (action) cross-section
for a 1 MeV electron of about 10–23 cm2. This cross-section represents only a mean value, since it is averaged
over the path length of an electron and neglects the fact
that there is a latency period of about 10 to 20 years between the initiating energy deposition events and the
manifestation of the tumor.
Transformation probabilities for alpha particles in the
energy range of 1-2 MeV/amu are about 10–13 for lung
cancer caused by inhaled radon decay products in man
[38], and between 10–9 to 10–11 for bone cancer in man
by 239Pu alpha particles [39]. These numbers lead to average transformation cross-sections between 10–15 and
10–19 cm2. Assuming a quality factor of 20, and allowing for differences in LET and particle range, alpha particle cross-sections show fair agreement with the electron data. However, all epidemiological in-vivo values
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are about 1012 times smaller than for in-vitro transformation. Since not all cells in an irradiated tissue volume are
likely to be susceptible to malignant transformation, the
actual probability will be higher by some orders of magnitude. Nevertheless, these numbers are still so very
small compared to atomic cross-sections as to suggest
contradiction. One possibility is that the linear extrapolation to low doses is invalid. An equivalent interpretation is that more than 1 electron or alpha particle must
interact with the nucleus of a cell to induce malignant
transformation.
Allowing for concomitant cell sterilization, the observed tumor frequency represents always the product of two probabilities, for transformation and for not
being killed [40]. Having in mind that cell killing has a
much higher probability than transformation, then in
order to get the observed linear dose-effect relationship
in the low dose region, the induction process must be
a power function of dose, as the result of the cooperation of at least two energy deposition events. This has
already been pointed out by Mole [37], who concludes
that for leukemia incidence in Japanese bomb survivors,
cancer induction is most probably a function of dose
squared. For the production of osteosarcoma by alpha
particles of radium in man, Marshall and Groer [41] put
forward a theory which postulates two initiation events
produced in a single cell by two alpha particles. Lloyd et
al. [35] observed even a nearly cubic dose response for
transformation of mouse embryo cells (CH 10T1/2) with
5.6 MeV alpha particles. Thus for electrons there is sufficient evidence that at least two energy deposition events
(from two different electrons) in a cell are a necessary
condition for carcinogenesis [40]. An equivalent interpretation, particularly for high LET radiation, might be
that induction results from the transformation of two
different transformed and most probably adjacent cells.
However, it is important to note here that specific biological differences between different kinds of malignant disease may play an important role in their induction and consequently in their interpretation in terms of
dose-effect relationships.
We wish to suggest yet a new line of evidence regarding the character of the dose-response curve
which we believe has not yet been considered, namely,
does one observe single or multiple tumor sites in radiation induced cancer. For doses causing an effect
above the background level, many-hit processes have
a steeper dose-response curve than single hit processes
[12]. Hence the probability increment for many-hit
processes per increment in dose may be substantially
greater than for single hit processes. Since the number
of cells at risk is the same, we would expect that multiple tumors are more common if the transformation
leading to carcinogenesis is a many-hit process. Observations of site multiplicity have never been properly reported, but this sort of information may prove of
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value in understanding the shape of the dose-response
curve at low doses.
Note that our track analyses of epidemiological data
imply that cancer induction is a statistical process, like
the exposure of photographic film. In both cases there
is no threshold, by definition. There is only an exposure level at which the probability exceeds background.
This is sometimes mistakenly identified as a threshold
exposure.
Because of the competitive effect of cell killing, occurring with much higher probability, we can estimate the
probability for transformation along the path of different energetic charged particles with the use of Figures
1 and 2. There we see that heavy nuclei can only cause
cancer at very high energies because all intersected cells
are killed at lower energies. On the other hand, protons,
deuterons, and alpha particles kill cells only at the very
end of their range, being effective therefore to induce a
cancer in the preceding part of their path. This allows
us to estimate the probability for cancer induction from
a single neutron, using information about the secondary particle spectrum in tissue [42,43]. There we see that
for 14 MeV neutrons, only protons, and to a lesser extent
also alpha particles can transform a cell. For 1 MeV neutrons, only protons can transform a cell (with the exception of the last cell in the path), since all heavier secondaries, e.g. B, C, N, and O nuclei have residual ranges at
which all cells are killed.
To repeat some of these conclusions for emphasis.
These calculations have demonstrated that cell killing is the dominant mode of action for the intersection
of high LET particles with cells. Transformation and
carcinogenesis can only take place in surviving cells.
A track structure interpretation of low dose effects
which result from single intersections of cells therefore strongly suggests that the quality factor for radiation induced carcinogenesis should be smaller for high
LET particles than for low LET radiations, practically
indistinguishable from zero for heavy charged particles. This raises doubts about whether cell killing is actually an important end-point for radiation protection
purposes, especially at low dose levels where only few
cells are affected by heavy ions, if the cells intersected
by the path of an ion can create no subsequent difficulties in later cell generations.
7. Conclusion
Biological effects of low doses of ionizing radiation
have been reconsidered in the new and somewhat different light of the structure of particle tracks along the
path of a single ion. In the calculations presented here, it
is always assumed that a single cell is the sensitive site
for a defined biological end-point, thus disregarding inter-cellular effects.
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No particular conceptual problems are presented
by 1-hit detectors, or by cell-killing with heavy ions. In
these cases there is clearly an initial slope demanded by
track structure theory and observed experimentally.
Questions, however, must be raised about the response of cells to electrons and other low “LET” radiations, about other biological end-points than cellular
inactivation. One can only suggest that quantitative results like those found here should stimulate qualitative
speculations.
When, on the average, at most only one in a hundred or one in a million 1 MeV electrons incident on a
single cell produces an observable effect in tissue, it is
reasonable to ask whether indeed the action probability is not negligibly small and whether the observed effect does not arise from the cooperative effect of several
electrons which interact with the nucleus of a cell. From
the track structure analysis we find new bases for considering whether a low probability for a biological event
is unacceptably and implausibly low, contradicting the
linear extrapolation from which it was calculated. The
new bases of comparison are the known cross-sections
for nuclear, atomic, and molecular processes. When an
action cross-section for a biological process is orders of
magnitude below molecular cross-sections, when it even
approaches nuclear cross-sections, we deem it to be unacceptably low. We conclude that there is an error in the
logical chain which led to the inferred value of the biological cross-section. The numerical values of the crosssection we have inferred from these calculations, from
the linear extrapolation to low dose, lead us to support
the view that cancer induction is a “many-hit” process
for electrons, and is at least a “2-hit” process for alpha
particles. Especially for alpha particles we must note
that to achieve two hits, that is two interactions leading
to the end-point, may require more than two alpha particle passages through the nucleus of a cell. We find no
basis for either a linear or a linear-quadratic extrapolation to low doses. And because of the statistical nature
of these processes, we find no basis for a threshold dose.
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